Hitting drug-resistant malaria infection with triazole-linked flavonoid-chloroquine hybrid compounds

Future Med Chem. 2022 Dec;14(24):1865-1880. doi: 10.4155/fmc-2022-0173. Epub 2022 Nov 22.

Abstract

Background: Malaria represents the major parasitic disease in tropical regions, and the development of new potent drugs is of pivotal importance. In this study, a series of hybrid molecules were designed by linking the 7-chloroquinoline core of chloroquine to different fluorinated flavonoid-related scaffolds. Materials & methods: Compounds were prepared by exploiting the click chemistry approach, allowing the introduction of a 1,2,3-triazole, a privileged structural motif in antiparasitic dug discovery. Results: Compounds 1b and 1c were the most interesting and were endowed with the highest in vitro activity, mainly against a resistant Plasmodium falciparum strain. They also inhibited hemozoin formation, and 1c was more effective than chloroquine against stage V gametocytes. Conclusion: The homoisoflavone core is a new, promising antimalarial scaffold that deserves further investigation.

Keywords: chloroquine hybrids; click chemistry; flavonoids; malaria prevention; malaria resistance; triazole linker.

MeSH terms

  • Antimalarials* / chemistry
  • Chloroquine / chemistry
  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Humans
  • Malaria* / drug therapy
  • Plasmodium falciparum
  • Triazoles / chemistry

Substances

  • Antimalarials
  • Flavonoids
  • Triazoles
  • Chloroquine